Lund OsteoArthritis Division - Molecular marker research group
11 – 20 of 170
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis : 2023 update
2024) In Annals of the Rheumatic Diseases(
- Contribution to journal › Article
-
Mark
“You don't put it down to arthritis” : A qualitative study of the first symptoms recalled by individuals with knee osteoarthritis
(
- Contribution to journal › Article
-
Mark
Serum ARGS-aggrecan in a phase 2 clinical trial targeting osteoarthritis
(
- Contribution to journal › Article
-
Mark
Sex and age differences in the patient-reported outcome measures and adherence to an osteoarthritis digital self-management intervention
(
- Contribution to journal › Article
- 2023
-
Mark
Sustained delivery of a heterodimer bone morphogenetic protein-2/7 via a collagen hydroxyapatite scaffold accelerates and improves critical femoral defect healing
(
- Contribution to journal › Article
-
Mark
Within-person change in patient-reported outcomes and their association with the wish to undergo joint surgery during a digital first-line intervention for osteoarthritis
(
- Contribution to journal › Article
-
Mark
Interpretation threshold values for patient-reported outcomes in patients participating in a digitally delivered first-line treatment program for hip or knee osteoarthritis
(
- Contribution to journal › Article
-
Mark
Thirty years of publishing osteoarthritis research in perspective — a special journal issue to mark the 30th anniversary of Osteoarthritis and Cartilage
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
An Economic Model for Estimating Trial Costs with an Application to Placebo Surgery Trials
(
- Contribution to journal › Article
-
Mark
Association of Traumatic Knee Injury With Radiographic Evidence of Knee Osteoarthritis in Military Officers
(
- Contribution to journal › Article